Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

9 citing papers in PubMed.

1. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.Diabetologia · 1991
   Trial
2. ACE-inhibition increases hepatic and extrahepatic sensitivity to insulin in patients with type 2 (non-insulin-dependent) diabetes mellitus and arterial hypertension.Diabetologia · 1991
   Trial
3. To bridge science and patient care in diabetes.Diabetologia · 1996
   Review
4. Guidelines for management of hypertension. Metabolic effects of drug treatment exaggerated.BMJ (Clinical research ed.) · 1994
   Article
5. Renal long-term effects of calcium antagonist treatment in patients with diabetes mellitus.The Clinical investigator · 1992
   Review
6. Recent Advances in Pharmacological Management of Hypertension in Diabetic Patients with Nephropathy : Effects of Antihypertensive Drugs on Kidney Function and Insulin Sensitivity.Drugs · 1992
   Review
7. Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?Diabetologia · 1991
   Article
8. Enalapril and metoprolol in diabetic nephropathy.BMJ (Clinical research ed.) · 1990
   Article
9. Enalapril and metoprolol in diabetic nephropathy.BMJ (Clinical research ed.) · 1990
   Article

Corrections and comments

• Commented on by
  Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus?1991

Authors and funding

4 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as